Beyond MHC binding: immunogenicity prediction tools to refine neoantigen selection in cancer patients
In the last years, multiple efforts have been made to accurately predict neoantigens derived from somatic mutations in cancer patients, either to develop personalized therapeutic vaccines or to study immune responses after cancer immunotherapy. In this context, the increasing accessibility of paired...
Main Authors: | Ibel Carri, Erika Schwab, Enrique Podaza, Heli M. Garcia Alvarez, José Mordoh, Morten Nielsen, María Marcela Barrio |
---|---|
Format: | Article |
Language: | English |
Published: |
Open Exploration Publishing Inc.
2023-04-01
|
Series: | Exploration of Immunology |
Subjects: | |
Online Access: | https://www.explorationpub.com/Journals/ei/Article/100391 |
Similar Items
-
IMPROVE: a feature model to predict neoepitope immunogenicity through broad-scale validation of T-cell recognition
by: Annie Borch, et al.
Published: (2024-04-01) -
Evaluation of T-Cell Responses Against Shared Melanoma Associated Antigens and Predicted Neoantigens in Cutaneous Melanoma Patients Treated With the CSF-470 Allogeneic Cell Vaccine Plus BCG and GM-CSF
by: Enrique Podaza, et al.
Published: (2020-06-01) -
Immunological analysis of hybrid neoantigen peptide encompassing class I/II neoepitope-pulsed dendritic cell vaccine
by: Shinji Morisaki, et al.
Published: (2023-10-01) -
Predicting T cell recognition of MHC class I restricted neoepitopes
by: Zeynep Koşaloğlu-Yalçın, et al.
Published: (2018-11-01) -
SIGANEO: Similarity network with GAN enhancement for immunogenic neoepitope prediction
by: Yilin Ye, et al.
Published: (2023-01-01)